Biopharma
Biopharma, officially known as Biopharma Limited, is a leading player in the biopharmaceutical industry, headquartered in Bangladesh (BD). Established in 2006, the company has rapidly expanded its operations across South Asia, focusing on the development and manufacturing of innovative biopharmaceutical products. Specialising in monoclonal antibodies, biosimilars, and recombinant proteins, Biopharma distinguishes itself through its commitment to quality and affordability, catering to both local and international markets. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. With a strong emphasis on research and development, Biopharma continues to contribute to the healthcare landscape, making strides in the treatment of various diseases while maintaining a reputation for excellence in the biopharma sector.
DitchCarbon Score
How does Biopharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biopharma's score of 0 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biopharma's reported carbon emissions
Biopharma, headquartered in BD, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or documented initiatives, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biopharmaceutical industry. As the sector increasingly focuses on sustainability, Biopharma's future commitments and strategies will be crucial in aligning with industry standards and expectations for reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biopharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
